Sudeep Pharma (BOM:544619) Current Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544619 Sudeep Pharma Ltd BOM:544619
21 GF Score
Price ₹1,154.95
! 8 Warning Signs
View Full Analysis

What is Sudeep Pharma Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sudeep Pharma's current ratio for the quarter that ended in Jun. 2026 was .

Sudeep Pharma has a current ratio of . It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Sudeep Pharma has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Sudeep Pharma's Current Ratio or its related term are showing as below:

BOM:544619' s Current Ratio Range Over the Past 10 Years
Min: 1.35   Med: 2.43   Max: 3.09
Current: 3.09

During the past 5 years, Sudeep Pharma's highest Current Ratio was 3.09. The lowest was 1.35. And the median was 2.43.

BOM:544619's Current Ratio is ranked better than
69.47% of 999 companies
in the Drug Manufacturers industry
Industry Median: 1.92 vs BOM:544619: 3.09

Sudeep Pharma  (BOM:544619) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Sudeep Pharma Current Ratio Related Terms


Sudeep Pharma Current Ratio Historical Data

* Premium members only.

The historical data trend for Sudeep Pharma's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudeep Pharma Current Ratio Chart

Sudeep Pharma Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Current Ratio
1.33 1.35 2.01 2.43 3.09

Sudeep Pharma Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Ratio Get a 7-Day Free Trial - 2.64 - 3.09 -

BOM:544619 vs ZTS: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sudeep Pharma's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sudeep Pharma Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sudeep Pharma's Current Ratio distribution charts can be found below:

* The bar in red indicates where Sudeep Pharma's Current Ratio falls into.


BOM:544619
21GF Score
Sudeep Pharma Ltd BOM:544619
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sudeep Pharma Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Sudeep Pharma's Current Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Current Ratio (A: Mar. 2026 )=Total Current Assets (A: Mar. 2026 )/Total Current Liabilities (A: Mar. 2026 )
=6239.66/2019.625
=3.09

Sudeep Pharma's Current Ratio for the quarter that ended in Jun. 2026 is calculated as

Current Ratio (Q: Jun. 2026 )=Total Current Assets (Q: Jun. 2026 )/Total Current Liabilities (Q: Jun. 2026 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sudeep Pharma Business Description

Other Exchanges SUDEEPPHRM:India
Address Gotri-Sevasi Road, 601-602, 6th floor, Sears II, East Wing, Towers - 2, Sevasi, Vadodara, GJ, IND, 391101
Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
21GF Score

Get the complete analysis for BOM:544619

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,154.95
Price